CIK: 0000924223
申告総資産額
$39.8億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CELG | Celgene CORP | 株式-その他 | 16.77% | +0.49% | -7.02% | |
| 2 | ✓ | Isis Pharmaceuticals INC | 株式-その他 | 14.71% | — | -7.29% | |
| 3 | GILD | Gilead Sciences INC | 株式-ヘルスケア | 12.41% | -0.80% | -1.95% | |
| 4 | INCY | Incyte CORP | 株式-ヘルスケア | 9.89% | +0.07% | -11.09% | |
| 5 | VRTX | Vertex Pharmaceuticals INC | 株式-ヘルスケア | 5.79% | -1.27% | — | |
| 6 | ALXN | Alexion Pharmaceuticals INC | 株式-その他 | 4.79% | +0.37% | -2.66% | |
| 7 | MODV | ModivCare Inc. | 株式-その他 | 4.73% | — | — | |
| 8 | ✓ | Ariad Pharmaceuticals INC | 株式-その他 | 3.69% | — | +18.42% | |
| 9 | HALO | Halozyme Therapeutics INC | 株式-ヘルスケア | 3.31% | -0.53% | -2.31% | |
| 10 | IMGNEUR | Immunogen INC | 株式-その他 | 3.03% | — | +0.42% | |
| 11 | ✓ | Pharmacyclics INC | 株式-その他 | 3.00% | — | — | |
| 12 | ✓ | Synageva Biopharma CORP | 株式-その他 | 2.46% | — | +1234.48% | |
| 13 | ✓ | Onyx Pharmaceuticals INC | 株式-その他 | 2.31% | — | -37.81% | |
| 14 | TBPH | Theravance Biopharma, Inc. | 株式-その他 | 1.98% | — | — | |
| 15 | REGN | Regeneron Pharmaceuticals | 株式-ヘルスケア | 1.74% | -0.82% | EXIT | |
| 16 | ✓ | Endocyte INC | 株式-その他 | 1.65% | — | -2.99% | |
| 17 | ALNY | Alnylam Pharmaceuticals INC | 株式-ヘルスケア | 1.64% | +0.16% | +3.63% | |
| 18 | CLVSEUR | Clovis Oncology INC | 株式-その他 | 1.26% | — | — | |
| 19 | INFIQ | Infinity Pharmaceuticals INC | 株式-その他 | 1.23% | — | +19.35% | |
| 20 | NBIX | Neurocrine Biosciences INC | 株式-ヘルスケア | 1.20% | -0.19% | — | |
| 21 | ✓ | Optimer Pharmaceuticals INC | 株式-その他 | 0.97% | — | -1.69% | |
| 22 | T8S | Tesaro INC | 株式-その他 | 0.79% | — | — | |
| 23 | ✓ | Idenix Pharmaceuticals INC | 株式-その他 | 0.35% | — | — | |
| 24 | ACHNEUR | Achillion Pharmaceuticals | 株式-その他 | 0.29% | — | +5.95% |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | ✓ | Synageva Biopharma CORP | +2.3% | +1234.48% | 増加 |
| 2 | INCY | Incyte CORP | +1.4% | -11.09% | 減少 |
| 3 | ALNY | Alnylam Pharmaceuticals INC | +0.6% | +3.63% | 増加 |
| 4 | HALO | Halozyme Therapeutics INC | +0.1% | -2.31% | 減少 |
| 5 | ✓ | Idenix Pharmaceuticals INC | 0% | — | 変化なし |
| 6 | INFIQ | Infinity Pharmaceuticals INC | 0% | +19.35% | 増加 |
| 7 | ✓ | Ariad Pharmaceuticals INC | -0.2% | +18.42% | 増加 |
| 8 | ✓ | Isis Pharmaceuticals INC | -0.3% | -7.29% | 減少 |
| 9 | ALXN | Alexion Pharmaceuticals INC | -0.4% | -2.66% | 減少 |
| 10 | MODV | ModivCare Inc. | -0.4% | — | 変化なし |
| 11 | TBPH | Theravance Biopharma, Inc. | -0.5% | — | 変化なし |
| 12 | ✓ | Optimer Pharmaceuticals INC | -0.5% | -1.69% | 減少 |
| 13 | ✓ | Endocyte INC | -0.6% | -2.99% | 減少 |
| 14 | ACHNEUR | Achillion Pharmaceuticals | -0.7% | +5.95% | 増加 |
| 15 | IMGNEUR | Immunogen INC | -0.9% | +0.42% | 増加 |
| 16 | ✓ | Onyx Pharmaceuticals INC | -1.1% | -37.81% | 減少 |
| 17 | GILD | Gilead Sciences INC | -1.3% | -1.95% | 減少 |
| 18 | CELG | Celgene CORP | -1.4% | -7.02% | 減少 |
| 19 | VRTX | Vertex Pharmaceuticals INC | -2.3% | — | 変化なし |
| 20 | ✓ | Pharmacyclics INC | — | NEW | 新規購入 |
| 21 | REGN | Regeneron Pharmaceuticals | — | NEW | 新規購入 |
| 22 | CLVSEUR | Clovis Oncology INC | — | NEW | 新規購入 |
| 23 | NBIX | Neurocrine Biosciences INC | — | NEW | 新規購入 |
| 24 | T8S | Tesaro INC | — | NEW | 新規購入 |
| 25 | BMRN | Biomarin Pharmaceutical INC | — | EXIT | 全売却 |
| 26 | MDCOUSD | Medicines Company | — | EXIT | 全売却 |
| 27 | ✓ | Dendreon CORP | — | EXIT | 全売却 |
| 28 | ✓ | Trius Therapeutics INC | — | EXIT | 全売却 |